Pfizer plans to sell the Covid vaccine it developed with BioNTech at $110 to $130 per dose for teens and adults once the U.S. government stops paying for them, the drugmaker said Friday.

The estimated price for Pfizer’s shot is in line with other adult vaccinations, such as for hepatitis and shingles, which can range from as little as $13 to more than $200, according to the Centers for Disease Control and Prevention. 

The $110 to $130 price tag is the list price, meaning people with Medicare or private health insurance would most likely pay only a fraction of that cost or nothing at all, said Cynthia Cox, vice president and director for the program on the Affordable Care Act for KFF, also known as the Kaiser Family Foundation. Insurers, Cox noted, had been expecting the price to be around $100.

Pfizer said the price takes into account the “value” of the vaccine as well as the cost it takes to make it.

The shots will be packaged in a single-dose vial, the company said, rather than the multi-dose vials that have been used throughout the pandemic.